tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Edgewise Therapeutics: Strong Financial Health and Promising Clinical Advances Drive Buy Rating
PremiumRatingsEdgewise Therapeutics: Strong Financial Health and Promising Clinical Advances Drive Buy Rating
2M ago
Edgewise Therapeutics reports Q2 EPS (34c), consensus (42c)
Premium
The Fly
Edgewise Therapeutics reports Q2 EPS (34c), consensus (42c)
2M ago
Peloton upgraded, Booking downgraded: Wall Street’s top analyst calls
Premium
The Fly
Peloton upgraded, Booking downgraded: Wall Street’s top analyst calls
2M ago
Edgewise Therapeutics Announces Positive Sevasemten Results
PremiumCompany AnnouncementsEdgewise Therapeutics Announces Positive Sevasemten Results
3M ago
Morning Movers: Shell ticks higher after denying interest in BP deal
Premium
The Fly
Morning Movers: Shell ticks higher after denying interest in BP deal
3M ago
Edgewise update in line with expectations, says Leerink
Premium
The Fly
Edgewise update in line with expectations, says Leerink
3M ago
Promising Developments in Edgewise Therapeutics’ Muscular Dystrophy Programs Drive Buy Rating
PremiumRatingsPromising Developments in Edgewise Therapeutics’ Muscular Dystrophy Programs Drive Buy Rating
5M ago
Edgewise Therapeutics Reports Strong Q1 2025 Progress
Premium
Company Announcements
Edgewise Therapeutics Reports Strong Q1 2025 Progress
5M ago
Edgewise Therapeutics reports Q1 EPS (43c), consensus (42c)
Premium
The Fly
Edgewise Therapeutics reports Q1 EPS (43c), consensus (42c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100